Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FAPI-74 PET/CT vs 18F-FDG PET/CT in Metastatic Invasive Lobular Breast Cancer
NCT07285993Phase 2Not yet recruiting
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of [18F]-FAPI-74 in breast cancer. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
[18F]-FAPI-74
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07285993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07285993.